JP2017500590A - 乳がんの予後診断方法 - Google Patents

乳がんの予後診断方法 Download PDF

Info

Publication number
JP2017500590A
JP2017500590A JP2016557167A JP2016557167A JP2017500590A JP 2017500590 A JP2017500590 A JP 2017500590A JP 2016557167 A JP2016557167 A JP 2016557167A JP 2016557167 A JP2016557167 A JP 2016557167A JP 2017500590 A JP2017500590 A JP 2017500590A
Authority
JP
Japan
Prior art keywords
icd
nuclear
score
breast cancer
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016557167A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017500590A5 (enExample
Inventor
ポール ウォルフィッシュ
ポール ウォルフィッシュ
ランジュ ラルハン
ランジュ ラルハン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/099,529 external-priority patent/US20140187438A1/en
Priority claimed from US14/501,020 external-priority patent/US20150094224A1/en
Application filed by Individual filed Critical Individual
Publication of JP2017500590A publication Critical patent/JP2017500590A/ja
Publication of JP2017500590A5 publication Critical patent/JP2017500590A5/ja
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2016557167A 2013-12-06 2014-12-05 乳がんの予後診断方法 Pending JP2017500590A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US14/099,529 US20140187438A1 (en) 2010-05-04 2013-12-06 Methods and Compositions for the Diagnosis and Treatment of Epithelial Cancers
US14/099,529 2013-12-06
US14/501,020 2014-09-29
US14/501,020 US20150094224A1 (en) 2010-05-04 2014-09-29 Methods for the diagnosis or prognosis of breast cancer
PCT/CA2014/051176 WO2015081446A1 (en) 2013-12-06 2014-12-05 Methods for the prognosis of breast cancer

Publications (2)

Publication Number Publication Date
JP2017500590A true JP2017500590A (ja) 2017-01-05
JP2017500590A5 JP2017500590A5 (enExample) 2018-01-25

Family

ID=53272695

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016557167A Pending JP2017500590A (ja) 2013-12-06 2014-12-05 乳がんの予後診断方法

Country Status (5)

Country Link
EP (1) EP3077812A4 (enExample)
JP (1) JP2017500590A (enExample)
AU (1) AU2014360606A1 (enExample)
CA (1) CA2932846A1 (enExample)
WO (1) WO2015081446A1 (enExample)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010246558A (ja) * 2003-05-29 2010-11-04 Millennium Pharmaceuticals Inc 乳癌の同定、評価、予防、および治療のための組成物、キットおよび方法
US20110097732A1 (en) * 2009-10-26 2011-04-28 Medinnova As Novel biomarker for the prognosis of breast cancer
US20110275530A1 (en) * 2010-05-04 2011-11-10 Paul Walfish Methods and compositions for the diagnosis and treatment of epithelial cancers

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010246558A (ja) * 2003-05-29 2010-11-04 Millennium Pharmaceuticals Inc 乳癌の同定、評価、予防、および治療のための組成物、キットおよび方法
US20110097732A1 (en) * 2009-10-26 2011-04-28 Medinnova As Novel biomarker for the prognosis of breast cancer
US20110275530A1 (en) * 2010-05-04 2011-11-10 Paul Walfish Methods and compositions for the diagnosis and treatment of epithelial cancers

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HE, H.C.-H. ET AL.: "An Ep-ICD Based Index Is a Marker of Aggressiveness and Poor Prognosis in Thyroid Carcinoma", PLOS ONE, vol. 7, no. 9, JPN6018042649, September 2012 (2012-09-01), pages 42893, XP055348182, ISSN: 0003908587, DOI: 10.1371/journal.pone.0042893 *
RALHAN, R. ET AL.: "Nuclear and Cytoplasmic Accumulation of Ep-ICD Is Frequently Detected in Human Epithelial Cancers", PLOS ONE, vol. 5, no. 11, JPN6018042647, November 2010 (2010-11-01), pages 14130, ISSN: 0003908586 *

Also Published As

Publication number Publication date
CA2932846A1 (en) 2015-06-11
WO2015081446A1 (en) 2015-06-11
EP3077812A4 (en) 2017-06-07
EP3077812A1 (en) 2016-10-12
WO2015081446A9 (en) 2016-03-31
AU2014360606A1 (en) 2016-07-21

Similar Documents

Publication Publication Date Title
Botti et al. Programmed death ligand 1 (PD-L1) expression in primary angiosarcoma
US9618512B2 (en) Biomarker for breast cancer
Vera-Román et al. Comparative assays for the HER-2/neu oncogene status in breast cancer
CN102625849B (zh) 侦测致死细胞的方法与材料及其应用
Tsuna et al. Significance of S100A4 as a prognostic marker of lung squamous cell carcinoma
US20080166733A1 (en) Method for determining the prognosis of cancer patients by measuring levels of bag expression
Liang et al. Assessment of biomarkers for clinical diagnosis of papillary thyroid carcinoma with distant metastasis
JP2014519818A (ja) 前立腺癌用の予測バイオマーカ
JP2012501440A (ja) 内分泌処置予測因子としてのａｎｌｎタンパク質
JP5403534B2 (ja) 食道癌の予後予測のための情報を提供する方法
US20160313335A1 (en) Methods for the Prognosis of Breast Cancer
CN103180455B (zh) 侦测致死系统的方法及其用途
JP2022153482A (ja) 癌のバイオマーカーとしてのｐｄ－ｅｃｇｆ
US11791043B2 (en) Methods of prognosing early stage breast lesions
JP2017500590A (ja) 乳がんの予後診断方法
EP2269073B1 (en) A method of assessing cancer status in a breast cancer patient
Van et al. Association of BRAF V600E immunoexpression with clinicopathological variant groups in papillary thyroid carcinoma
US20150018239A1 (en) Biomarker set for identifying a severe form of cancer
Jayasinghe et al. Circulating Biomarkers in the Management of Breast Cancer
WO2016106453A1 (en) Nuclear ep-icd as a prognosis marker for prostate cancer
WO2016127999A1 (en) Neuropeptide y as a prognostic marker of prostate cancer
Abdelbary et al. Role of ERG, PTEN and KI67 proteins expression in prognosis of metastatic prostate cancer
KR20240161980A (ko) 갑상선암의 진단을 위한 신규한 바이오 마커
AU2012326434A1 (en) Predictive biomarkers for breast cancer
Iweala et al. Scientific African

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20171205

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20171205

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20180928

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20181101

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20190606